FAR 26.5—Subpart 26.5

Scope of subpart.

FAR 26.500 is a scope provision that tells readers what Subpart 26.5 is for: it implements the Drug-Free Workplace requirements in 41 U.S.C. chapter 81. In practical terms, this means the subpart is the FAR’s bridge between the statute and federal procurement, establishing that the rules in this subpart are not standalone policy but the contracting-system implementation of a governmentwide drug-free workplace mandate. The section itself does not create detailed contractor obligations or procedures; instead, it signals that the subpart governs how the statutory drug-free workplace requirements are applied in federal contracting. For contracting officers and contractors, the significance is that any requirements, certifications, clauses, or compliance actions found later in the subpart are grounded in this statutory authority and must be read as part of that broader legal framework. This section therefore serves as the entry point for understanding when and why drug-free workplace requirements appear in federal contracts and related procurement actions.

Applicability.

FAR 26.501 explains when the requirements of FAR Subpart 26.5 apply and when they do not. In general, the subpart applies to federal contracts, including contracts awarded to 8(a) contractors under FAR Subpart 19.8 and contract modifications that require a justification and approval under FAR Subpart 6.3. The section then lists specific exclusions: contracts at or below the simplified acquisition threshold, except that the subpart still applies to all contracts of any value awarded to an individual; acquisitions of commercial products and commercial services under FAR Part 12; work performed outside the United States and its outlying areas, including any part of a contract performed there; certain law enforcement agency contracts when the agency head or designee determines the subpart would be inappropriate for undercover operations; and situations where applying the subpart would conflict with U.S. international obligations or the laws and regulations of a foreign country. Practically, this section tells contracting personnel when the subpart’s special requirements must be considered and when they are not required, which is critical for proper acquisition planning, solicitation drafting, and contract administration.

Authority.

FAR 26.502 explains the legal authority for the drug-free workplace requirements in federal contracting. It ties the FAR subpart to 41 U.S.C. chapter 81, which is the statutory basis for requiring contractors to maintain drug-free workplaces and for the government to enforce those requirements through contract clauses and related procedures. In practical terms, this section tells readers where the government’s power comes from to require contractor compliance, and it frames the rest of the subpart’s rules on workplace policies, employee awareness, and consequences for violations. Although the text is brief, it is important because it establishes that the drug-free workplace requirements are not optional policy preferences; they are grounded in federal law and therefore can be incorporated into contracts and enforced as a condition of doing business with the Government. For contractors, this means compliance obligations arise from statute-backed contract requirements, not just internal company policy. For contracting officers and agencies, it confirms that the FAR provisions in this area have a clear legal foundation.

Definitions.

FAR 26.503 is the definitions section for this subpart, and it establishes the meaning of the terms that control how the subpart is applied in federal contracting. It defines controlled substance, conviction, criminal drug statute, employee, directly engaged, and individual. These definitions matter because they determine who is covered by the subpart’s drug-free workplace requirements, what kinds of drug-related conduct trigger consequences, and when a contractor is treated as an individual rather than an organization. In practice, the definitions set the scope for compliance obligations, certification statements, workplace policies, and any enforcement or remedy actions tied to drug-related violations. The section is especially important for contractors because the reach of the rules depends on whether a person is a covered employee and whether a contractor qualifies as an individual with no more than one employee. For contracting officers and agencies, these definitions are the threshold for deciding when the subpart applies and how broadly to interpret contractor responsibilities.

Policy.

FAR 26.504 sets the core policy for the Drug-Free Workplace Act requirements in federal contracting. It explains when a contractor or offeror must agree to maintain a drug-free workplace, what that agreement must include, and how the rules differ for organizations versus individuals. The section covers the responsibility determination for non-individual offerors on contracts above the simplified acquisition threshold, the specific workplace policy and employee-notification steps the contractor must implement, the employee duty to report drug convictions, the contractor’s duty to notify the contracting officer, the required response to a conviction, and the need for a good-faith effort to keep the workplace drug-free. It also addresses the separate rule for individual contractors, who must agree not to use, possess, distribute, dispense, or manufacture controlled substances while performing the contract. Finally, it sets the timing for compliance after award, including the normal 30-day implementation period for contracts of 30 days or more and the “as soon as possible” standard for shorter contracts. In practice, this section matters because failure to meet these conditions can affect responsibility determinations, contract award eligibility, and post-award compliance obligations.

Suspension of payments, termination of contract, and debarment and suspension actions.

FAR 26.505 explains what a contracting officer may do when there is evidence that a contractor is not complying with the Drug-Free Workplace requirements in FAR 52.226-7. It covers three main enforcement actions: suspending contract payments, terminating the contract for default, and referring the matter for suspension or debarment action under FAR subpart 9.4. The section also identifies the specific triggers for these actions, namely failure to comply with the Drug-Free Workplace clause or a pattern of employee drug convictions that shows the contractor did not make a good-faith effort to maintain a drug-free workplace. In addition, it allows a limited waiver by the agency head, but only when necessary to avoid severe disruption to agency operations or harm to the Federal Government or the public, and that waiver authority cannot be delegated. In practice, this section gives agencies a strong enforcement tool for workplace drug policy compliance while requiring written findings, procedural compliance, and referral to suspension/debarment officials when action is taken.

Contract clause.

FAR 26.506 is a very short but important prescription rule that tells contracting officers when to include the Drug-Free Workplace clause at FAR 52.226-7 in solicitations and contracts. It works together with FAR 26.501, which contains the limited exceptions to the drug-free workplace requirement, so the clause is inserted unless an exception applies. In practice, this section is about ensuring the government’s drug-free workplace policy is carried into the contract through a mandatory clause, rather than left to discretion. The section does not itself define the full substance of the contractor’s obligations; instead, it directs the reader to the clause text at 52.226-7, which contains the detailed requirements. For contracting officers, the practical significance is simple: check whether an exception under 26.501 applies, and if not, include the clause in both the solicitation and the resulting contract. For contractors, the significance is that the clause may impose compliance obligations as a condition of award and performance, so they should identify it early and plan for the associated workplace policy, notice, and enforcement requirements.